Outbreaks have been reported in the US of transmissible Candida auris fungal infections that have been found to be resistant to drugs and difficult to treat. In a report published on 22 July the Centers for Disease Control and Prevention said that two clusters of cases had been reported in Washington, DC, and in Texas.1 C auris is a different organism from the “black fungus” reported among covid-19 patients in India. “These two simultaneous, independent clusters of pan- or echinocandin resistant C auris cases in patients with overlapping inpatient health care exposures and without previous echinocandin use provide the first evidence suggesting that pan- or echinocandin-resistant C auris strains might have been transmitted in US health care settings . …
No takes yet. Share an insight, caveat, or question.
Janice Hopkins Tanne (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: